Literature DB >> 29445123

Psychosocial risk predicts high readmission rates for hematopoietic cell transplant recipients.

Daniel R Richardson1, Ying Huang2, Heather L McGinty3, Patrick Elder2, Joanna Newlin4, Cyndi Kirkendall4, Leslie Andritsos2, Don Benson2, William Blum5, Yvonne Efebera2, Sam Penza2, Craig Hofmeister2, Samantha Jaglowski2, Rebecca Klisovic5, Sumithira Vasu2, Basem William2, Steven Devine2, Ashley E Rosko2.   

Abstract

Hematopoietic cell transplantation (HCT) is an intensive treatment resulting in disease control however subsequent psychosocial distress is common. Screening for psychosocial risk factors that contribute to morbidity is underutilized; moreover, the value in screening is uncertain. We performed a retrospective study of 395 HCT patients who were screened for psychosocial risk using the Transplant Evaluation Rating Scale (TERS). Patients were classified by psychosocial risk as no-risk (TERS = 26.5, 52%) vs. at-risk (TERS > 26.5, 48%), with at-risk patients stratified by cumulative deficits into mild risk (TERS = 27-35.5, 39%) and moderate risk (TERS > 35.5, 9%). At-risk patients were more likely to be readmitted within 90 days (mild risk HR = 1.62, p = 0.02; moderate risk HR = 2.50, p = 0.002). Prior psychiatric history (HR = 1.81, p = 0.002) and poor coping skills (HR = 1.64, p = 0.04) also influenced readmission. At-risk patients were more likely to be readmitted for infection (no-risk = 12% vs. at-risk = 25%, p = 0.002). Pre-HCT screening with the TERS did not predict survival or length of stay although at-risk patients are at a heighted risk of readmission. Implementing strategies to reduce readmission in higher risk patients is warranted.

Entities:  

Mesh:

Year:  2018        PMID: 29445123      PMCID: PMC6092254          DOI: 10.1038/s41409-018-0118-4

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  43 in total

1.  The Stanford Integrated Psychosocial Assessment for Transplantation (SIPAT): a new tool for the psychosocial evaluation of pre-transplant candidates.

Authors:  José R Maldonado; Holly C Dubois; Evonne E David; Yelizaveta Sher; Sermsak Lolak; Jameson Dyal; Daniela Witten
Journal:  Psychosomatics       Date:  2012 Mar-Apr       Impact factor: 2.386

2.  The Transplant Evaluation Rating Scale. A revision of the psychosocial levels system for evaluating organ transplant candidates.

Authors:  R K Twillman; C Manetto; D K Wellisch; D L Wolcott
Journal:  Psychosomatics       Date:  1993 Mar-Apr       Impact factor: 2.386

3.  Psychosocial vulnerability predicts psychosocial outcome after an organ transplant: results of a prospective study with lung, liver, and bone-marrow patients.

Authors:  Lutz Goetzmann; Richard Klaghofer; Regula Wagner-Huber; Jörg Halter; Annette Boehler; Beat Muellhaupt; Urs Schanz; Claus Buddeberg
Journal:  J Psychosom Res       Date:  2007-01       Impact factor: 3.006

4.  Psychological distress as a negative survival factor for patients with hematologic malignancies who underwent allogeneic hematopoietic stem cell transplantation.

Authors:  Ji Eun Park; Kyung Im Kim; Sung Soo Yoon; Bong Jin Hahm; Sang Min Lee; Jeong Hyun Yoon; Wan Gyoon Shin; Hye Suk Lee; Jung Mi Oh
Journal:  Pharmacotherapy       Date:  2010-12       Impact factor: 4.705

5.  Cancer-and-treatment-specific distress and its impact on posttraumatic stress in patients undergoing allogeneic hematopoietic stem cell transplantation (HSCT).

Authors:  Katharina Kuba; Peter Esser; Angela Scherwath; Lena Schirmer; Frank Schulz-Kindermann; Andreas Dinkel; Friedrich Balck; Uwe Koch; Nicolaus Kröger; Heide Götze; Anja Mehnert
Journal:  Psychooncology       Date:  2016-11-14       Impact factor: 3.894

6.  Pre-transplant depression as risk factor for survival of patients undergoing allogeneic haematopoietic stem cell transplantation.

Authors:  Norbert Grulke; Wolfgang Larbig; Horst Kächele; Harald Bailer
Journal:  Psychooncology       Date:  2008-05       Impact factor: 3.894

7.  Risk factors for readmission after allogeneic hematopoietic stem cell transplantation and impact on overall survival.

Authors:  Laura Spring; Shuli Li; Robert J Soiffer; Joseph H Antin; Edwin P Alyea; Brett Glotzbecker
Journal:  Biol Blood Marrow Transplant       Date:  2014-12-05       Impact factor: 5.742

8.  A prospective study of psychosocial morbidity in adult bone marrow transplant recipients.

Authors:  P L Jenkins; H Lester; J Alexander; J Whittaker
Journal:  Psychosomatics       Date:  1994 Jul-Aug       Impact factor: 2.386

9.  Assessment of psychological distress in prospective bone marrow transplant patients.

Authors:  P C Trask; A Paterson; M Riba; B Brines; K Griffith; P Parker; J Weick; P Steele; K Kyro; J Ferrara
Journal:  Bone Marrow Transplant       Date:  2002-06       Impact factor: 5.483

10.  Psychosocial factors predicting survival after allogeneic stem cell transplant.

Authors:  Brindha Pillay; Stuart J Lee; Lynda Katona; Sue Burney; Sharon Avery
Journal:  Support Care Cancer       Date:  2014-04-16       Impact factor: 3.603

View more
  3 in total

Review 1.  Psychiatric Care in Hematopoietic Stem Cell Transplantation.

Authors:  Zev M Nakamura; Rebekah P Nash; Laura J Quillen; Daniel R Richardson; Rebecca C McCall; Eliza M Park
Journal:  Psychosomatics       Date:  2019-01-19       Impact factor: 2.386

2.  The Transplant Evaluation Rating Scale predicts overall survival after allogeneic hematopoietic stem cell transplantation.

Authors:  Melhem M Solh; Dawn Speckhart; Scott R Solomon; Asad Bashey; Lawrence E Morris; Xu Zhang; H Kent Holland
Journal:  Blood Adv       Date:  2020-10-13

3.  Discharge Disposition Following Hematopoietic Cell Transplantation: Predicting the Need for Rehabilitation and Association with Survival.

Authors:  Sarah A Wall; Qiuhong Zhao; Sumithira Vasu; Ashley Rosko
Journal:  Transplant Cell Ther       Date:  2020-12-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.